Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

amyloidogenic apolipoprotein A-II, mouse

Known as: apolipoprotein A-II, type C, mouse, apolipoprotein A-II, amyloidogenic, mouse, Apoa2c, mouse 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Apolipoprotein A-II

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
A Consensus Method for the Prediction of ‘Aggregation-Prone’ Peptides in Globular Proteins
The purpose of this work was to construct a consensus prediction algorithm of 'aggregation-prone' peptides in globular proteins… Expand
  • table 1
  • figure 1
Is this relevant?
2012
2012
Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Actaea racemosa.
A screen of a library of synthetic drugs and natural product extracts identified a botanical extract that modulates the… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2010
2010
GNNQQNY--investigation of early steps during amyloid formation.
Protein aggregation has been implicated in the pathology of several neurodegenerative diseases, and a better understanding of how… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.
OBJECTIVES To explore mechanisms through which altered peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
The abnormal deposition of the amyloid beta-protein (Abeta) in the brain appears crucial to the pathogenesis of Alzheimer's… Expand
Is this relevant?
2005
2005
Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology
Abstract The brains of Alzheimer's disease (AD) patients contain large numbers of amyloid plaques that are rich in fibrils… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2005
2005
Characterization of two distinct beta2-microglobulin unfolding intermediates that may lead to amyloid fibrils of different morphology.
The self-assembly of beta(2)-microglobulin into fibrils leads to dialysis-related amyloidosis. pH-mediated partial unfolding is… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model
Aims/hypothesis. Type II (non-insulin-dependent) diabetes mellitus is a multifactorial disease in which pancreatic islet amyloid… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
1999
1999
Benzolactam (BL) enhances sAPP secretion in fibroblasts and in PC12 cells.
Activation of protein kinase C is known to favor the alpha-secretase processing of the Alzheimer's disease (AD) amyloid precursor… Expand
Is this relevant?
1995
1995
Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides
Acetylcholinesterase (AChE) colocalizes with amyloid-beta peptide (A beta) deposits present in the brain of Alzheimer's patients… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE